Detalhe da pesquisa
1.
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.
Blood
; 138(26): 2828-2837, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653242
2.
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Nat Med
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38886623
3.
The effect of oxygen impurities on the stability and structural properties of vacancy-ordered and -disordered ZrC x.
RSC Adv
; 12(6): 3198-3215, 2022 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35425389
4.
Stability and structural properties of vacancy-ordered and -disordered ZrC x.
RSC Adv
; 11(52): 32573-32589, 2021 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35974892
5.
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
J Clin Oncol
; 39(28): 3109-3117, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170745
6.
Influence and Sensitivity of Temperature and Microstructure on the Fluctuation of Creep Properties in Ni-Base Superalloy.
Materials (Basel)
; 13(21)2020 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33114398